Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality.
Saved in:
| Title: | Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality. |
|---|---|
| Authors: | Kosako Yost KC; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Ghai MB; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Aboona M; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Ali Q; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Rangan P; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine, Phoenix, AZ., Gomez P; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Nathan R; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Wong M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Wijarnpreecha K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Nevah Rubin MI; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Fallon M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Han MAT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ. |
| Source: | Transplantation direct [Transplant Direct] 2026 May 15; Vol. 12 (6), pp. e1935. Date of Electronic Publication: 2026 May 15 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101651609 Publication Model: eCollection Cited Medium: Print ISSN: 2373-8731 (Print) Linking ISSN: 23738731 NLM ISO Abbreviation: Transplant Direct Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
